Spots Global Cancer Trial Database for low molecular weight heparin
Every month we try and update this database with for low molecular weight heparin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism | NCT01164046 | Venous Thromboe... Neoplasms | low molecular w... vitamin K antag... | 18 Years - | University Medical Center Groningen | |
Optimal Prophylactic Method of Venous Thromboembolism (VTE) | NCT01448746 | Venous Thromboe... | low molecular w... | 20 Years - 75 Years | The Catholic University of Korea | |
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer | NCT00312013 | Thrombosis, Ven... | Nadroparin | 18 Years - | GlaxoSmithKline | |
Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) | NCT00475098 | Lung Cancer Non Small Cell ... | Tinzaparin sodi... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China | NCT02935530 | Gynecologic Neo... Venous Thromboe... Low Molecular W... Argatroban | s-LMWH LMWH Argatroban | 16 Years - 70 Years | Huazhong University of Science and Technology | |
Cancer Venous Thromboembolism (VTE) | NCT02073682 | Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Cancer | Edoxaban Dalteparin Low molecular w... | 18 Years - | Daiichi Sankyo | |
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer | NCT01803022 | Venous Thromboe... | 18 Years - | LEO Pharma | ||
The Roles of Tissue Factor in Malignant Gliomas | NCT00201903 | Venous Thromboe... Brain Tumors | 18 Years - | Ontario Clinical Oncology Group (OCOG) | ||
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery | NCT01267305 | Lung Neoplasms Esophageal Neop... Venous Thromboe... | Fondaparinux Nadroparin Calc... Nadroparin Calc... | 18 Years - | Shanghai Zhongshan Hospital | |
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery | NCT01267305 | Lung Neoplasms Esophageal Neop... Venous Thromboe... | Fondaparinux Nadroparin Calc... Nadroparin Calc... | 18 Years - | Shanghai Zhongshan Hospital | |
Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) | NCT00771563 | Non-Small Cell ... | cisplatin + doc... cisplatin + doc... | 18 Years - | University Hospital, Antwerp | |
Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) | NCT00771563 | Non-Small Cell ... | cisplatin + doc... cisplatin + doc... | 18 Years - | University Hospital, Antwerp | |
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery | NCT02334007 | Venous Thromboe... Lung Neoplasms Pulmonary Embol... | LMWH: Daltepari... Placebo | 18 Years - | McMaster University | |
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism | NCT01164046 | Venous Thromboe... Neoplasms | low molecular w... vitamin K antag... | 18 Years - | University Medical Center Groningen | |
Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis | NCT00450645 | Deep Vein Throm... Cancer | low molecular w... | 18 Years - | Azienda Ospedaliera Universitaria Policlinico | |
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism | NCT01164046 | Venous Thromboe... Neoplasms | low molecular w... vitamin K antag... | 18 Years - | University Medical Center Groningen | |
Study on Thrombosis Therapy in German Cancer Patients | NCT01559883 | Cancer Deep Vein Throm... Pulmonary Embol... | no intervention... | 18 Years - | LEO Pharma | |
Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients | NCT04248348 | Thrombosis Solid Cancer | Low Molecular W... | 18 Years - | Metaxa Hospital |